Safety and Efficacy of COVID‐19 Convalescent Plasma in Severe Pulmonary Disease: A Report of 17 Patients

Transfusion MedicineVolume 31, Issue 3 p. 217-220 LETTER TO THE EDITOR Safety and efficacy of COVID-19 convalescent plasma in severe pulmonary disease: A report of 17 patients Priya Pal, Priya Pal Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorMoayed Ibrahim, Moayed Ibrahim Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorAlex Niu, Alex Niu Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorKevin J. Zwezdaryk, Kevin J. Zwezdaryk Department of Microbiology and Immunology, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorElise Tatje, Elise Tatje Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorWilliam R. Robinson IV, William R. Robinson IV Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorLeta Ko, Leta Ko Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorIshwarya Satyavarapu, Ishwarya Satyavarapu Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorWallace E. Jones, Wallace E. Jones Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorAdeem Nachabe, Adeem Nachabe orcid.org/0000-0003-4683-5831 Department of Medicine, Louisiana State University School of Medicine, New Orleans, Louisiana, USASearch for more papers by this authorAlfred Luk, Alfred Luk Section of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorDavid M. Mushatt, David M. Mushatt Section of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorKarin Halvorson, Karin Halvorson Section of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorJoshua L. Denson, Joshua L. Denson Section of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorCharles C. Smith III, Charles C. Smith III Department of Pulmonary Diseases, Touro LCMC Health, New Orleans, Louisiana, USASearch for more papers by this authorFrancesco Simeone, Francesco Simeone Section of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorGaynelle Davis, Gaynelle Davis Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorSukhmani K. Gill, Sukhmani K. Gill Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorApril McDougal, April McDougal Section of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorAniko S. Vigh, Aniko S. Vigh Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorTim G. Peterson, Tim G. Peterson Section of Pathology and Laboratory Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorBo Ning, Bo Ning Department of Biochemistry and Molecular Biology, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorTony Hu, Tony Hu Department of Biochemistry and Molecular Biology, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorFrancisco Socola, Francisco Socola orcid.org/0000-0002-4002-9284 Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorJames Robinson, James Robinson Section of Pediatric Infectious Disease, Department of Pediatrics, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorHana Safah, Hana Safah Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorNakhle S. Saba, Corresponding Author Nakhle S. Saba [email protected] orcid.org/0000-0003-3206-2575 Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA Correspondence Nakhle S. Saba, Clinical Medicine, School of Medicine, Deming Department of Medicine, Section of Hematology and Medical Oncology, 1430 Tulane Ave. #8578, New Orleans, LA 70112, USA. Email: [email protected]Search for more papers by this author Priya Pal, Priya Pal Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorMoayed Ibrahim, Moayed Ibrahim Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorAlex Niu, Alex Niu Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorKevin J. Zwezdaryk, Kevin J. Zwezdaryk Department of Microbiology and Immunology, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorElise Tatje, Elise Tatje Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorWilliam R. Robinson IV, William R. Robinson IV Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorLeta Ko, Leta Ko Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorIshwarya Satyavarapu, Ishwarya Satyavarapu Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorWallace E. Jones, Wallace E. Jones Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorAdeem Nachabe, Adeem Nachabe orcid.org/0000-0003-4683-5831 Department of Medicine, Louisiana State University School of Medicine, New Orleans, Louisiana, USASearch for more papers by this authorAlfred Luk, Alfred Luk Section of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorDavid M. Mushatt, David M. Mushatt Section of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorKarin Halvorson, Karin Halvorson Section of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorJoshua L. Denson, Joshua L. Denson Section of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorCharles C. Smith III, Charles C. Smith III Department of Pulmonary Diseases, Touro LCMC Health, New Orleans, Louisiana, USASearch for more papers by this authorFrancesco Simeone, Francesco Simeone Section of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorGaynelle Davis, Gaynelle Davis Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorSukhmani K. Gill, Sukhmani K. Gill Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorApril McDougal, April McDougal Section of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorAniko S. Vigh, Aniko S. Vigh Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorTim G. Peterson, Tim G. Peterson Section of Pathology and Laboratory Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorBo Ning, Bo Ning Department of Biochemistry and Molecular Biology, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorTony Hu, Tony Hu Department of Biochemistry and Molecular Biology, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorFrancisco Socola, Francisco Socola orcid.org/0000-0002-4002-9284 Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorJames Robinson, James Robinson Section of Pediatric Infectious Disease, Department of Pediatrics, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorHana Safah, Hana Safah Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USASearch for more papers by this authorNakhle S. Saba, Corresponding Author Nakhle S. Saba [email protected] orcid.org/0000-0003-3206-2575 Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA Correspondence Nakhle S. Saba, Clinical Medicine, School of Medicine, Deming Department of Medicine, Section of Hematology and Medical Oncology, 1430 Tulane Ave. #8578, New Orleans, LA 70112, USA. Email: [email protected]Search for more papers by this author First published: 19 October 2020 https://doi.org/10.1111/tme.12729Citations: 4 Priya Pal, Moayed Ibrahim and Alex Niu are co-first authors. Hana Safah and Nakhle S. Saba sharedequal contribution. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Supporting Information Filename Description tme12729-sup-0001-AppendixS1.docxWord 2007 document , 28 KB Data S1. Supporting information. tme12729-sup-0002-TableS1.xlsxExcel 2007 spreadsheet , 13.1 KB Table S1. Supporting information. tme12729-sup-0003-TableS2.xlsxExcel 2007 spreadsheet , 12.9 KB Table S2. Supporting information. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. REFERENCES 1 WHO. WHO Coronavirus Disease (COVID-19) Dashboard, 2020. https://covid19.who.int/. Published 2020. Accessed September 19, 2020. Google Scholar 2Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 - preliminary report. N Engl J Med. 2020. 10.1056/NEJMoa2007764 PubMedWeb of Science®Google Scholar 3Graham BS, Ambrosino DM. History of passive antibody administration for prevention and treatment of infectious diseases. Curr Opin HIV AIDS. 2015; 10(3): 129-134. 10.1097/COH.0000000000000154 CASPubMedWeb of Science®Google Scholar 4Cheng Y, Wong R, Soo YO, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005; 24(1): 44-46. 10.1007/s10096-004-1271-9 CASPubMedWeb of Science®Google Scholar 5Valk SJ, Piechotta V, Chai KL, et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Cochrane Database Syst Rev. 2020; 5. PubMedWeb of Science®Google Scholar 6Ye M, Fu D, Ren Y, et al. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. J Med Virol. 2020; 92: 1890-1901. 10.1002/jmv.25882 CASPubMedWeb of Science®Google Scholar 7Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020; 323: 1582-1589. 10.1001/jama.2020.4783 CASPubMedWeb of Science®Google Scholar 8Li L, Zhang W, Hu Y, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA. 2020; 324: 460-470. 10.1001/jama.2020.10044 CASPubMedWeb of Science®Google Scholar 9Joyner MJ, Senefeld JW, Klassen SA, et al. Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience. medRxiv. 2020:2020.2008.2012.20169359. Google Scholar 10Liu STH, Lin H-M, Baine I, et al. Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study. Nat Med. 2020. 10.1038/s41591-020-1088-9 Web of Science®Google Scholar 11FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment. Another Achievement in Administration's Fight against Pandemic [press release], 2020. August 23, 2020. Google Scholar 12Huang Z, Tian D, Liu Y, et al. Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis. Biosens Bioelectron. 2020; 164:112316. 10.1016/j.bios.2020.112316 CASPubMedWeb of Science®Google Scholar 13Salazar E, Christensen PA, Graviss EA, et al. Treatment of coronavirus disease 2019 patients with convalescent plasma reveals a signal of significantly decreased mortality. Am J Pathol. 2020. Web of Science®Google Scholar 14Zeng QL, Yu ZJ, Gou JJ, et al. Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease 2019. J Infect Dis. 2020; 222(1): 38-43. 10.1093/infdis/jiaa228 PubMedWeb of Science®Google Scholar Citing Literature Volume31, Issue3June 2021Pages 217-220 ReferencesRelatedInformation